We are clearly disappointed that the Qualified Bidders did not place an acceptable offer for BioAmber,” Eno said in a statement. “We will continue to be actively engaged with potential investors to seek an acceptable transaction and avoid the liquidation of the company’s assets. Most importantly, I’d like to thank our dedicated and highly capable employees for their outstanding service to the company.
News 
Market Data 
Discover 
AI
